- Home
- ISPC vs NBY Comparison
ISPC vs NBY Comparison
Compare ISPC & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPC
- NBY
- Stock Information
- Founded
- ISPC 2009
- NBY 2000
- Country
- ISPC United States
- NBY United States
- Employees
- ISPC N/A
- NBY N/A
- Industry
- ISPC Precision Instruments
- NBY
- Sector
- ISPC Health Care
- NBY
- Exchange
- ISPC Nasdaq
- NBY Nasdaq
- Market Cap
- ISPC 3.1M
- NBY 3.5M
- IPO Year
- ISPC 2021
- NBY 2007
- Fundamental
- Price
- ISPC $0.94
- NBY $0.60
- Analyst Decision
- ISPC
- NBY Strong Buy
- Analyst Count
- ISPC 0
- NBY 1
- Target Price
- ISPC N/A
- NBY $0.85
- AVG Volume (30 Days)
- ISPC 51.4K
- NBY 32.1K
- Earning Date
- ISPC 08-05-2025
- NBY 08-12-2025
- Dividend Yield
- ISPC N/A
- NBY N/A
- EPS Growth
- ISPC N/A
- NBY N/A
- EPS
- ISPC N/A
- NBY 0.57
- Revenue
- ISPC $8,058,631.00
- NBY $9,781,000.00
- Revenue This Year
- ISPC $35.93
- NBY $23.91
- Revenue Next Year
- ISPC N/A
- NBY $32.05
- P/E Ratio
- ISPC N/A
- NBY $1.33
- Revenue Growth
- ISPC N/A
- NBY 20.52
- 52 Week Low
- ISPC $0.86
- NBY $0.36
- 52 Week High
- ISPC $11.80
- NBY $2.47
- Technical
- Relative Strength Index (RSI)
- ISPC 37.62
- NBY 53.58
- Support Level
- ISPC $0.86
- NBY $0.56
- Resistance Level
- ISPC $0.97
- NBY $0.64
- Average True Range (ATR)
- ISPC 0.06
- NBY 0.03
- MACD
- ISPC -0.02
- NBY -0.00
- Stochastic Oscillator
- ISPC 18.79
- NBY 44.44
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.